摘要
间质性肺疾病(interstitial lung disease,ILD)属于呼吸系统疑难杂症,主要治疗药物是糖皮质激素和免疫抑制剂,药物选择少,副作用较大。近年来随着新型抗纤维药物临床治疗数据的增多,给ILD患者的治疗带来了希望,本文就新型抗纤维化药物吡非尼酮(pirfenidone,PFD)和尼达尼布在ILD中的临床应用情况进行回顾总结。
Interstitial lung disease(ILD)is a type of rare and complicated respiratory diseases.The main therapeutic drugs include glucocorticoid and immunosuppressant,which are of less choice and greater side effects.In recent years,it brings hope to the treatment of patients with ILD with the increase of clinical treatment data of new anti-fibrosis drugs.This article reviewed the literatures on the clinical application of new anti-fibrosis drugs pirfenidone(PFD)and nintedanib in ILD.
作者
冯娜
李学任
彭守春
FENG Na;LI Xue-ren;PENG Shou-chun(The Hospital of Dongli in Dongli district of Tianjin,Tianjin 300300,China)
出处
《武警后勤学院学报（医学版）》
CAS
2018年第8期710-713,共4页
Journal of Logistics University of PAP（Medical Sciences）
